Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by García-Pardo, L.
Right arrow Articles by Bárcena, J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Pardo, L.
Right arrow Articles by Bárcena, J.A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 5, No. 10, 914-919, October 1999
© 1999 European Society of Human Reproduction and Embryology


Regulation of ovarian function

Immunolocalization of glutaredoxin in the human corpus luteum

L. García-Pardo1, M.D. Granados3, F. Gaytán2, C.A. Padilla3, E. Martínez-Galisteo3, C. Morales1, J.E. Sánchez-Criado2 and J.A. Bárcena3,4

1 Departments of Pathology and 2 Cell Biology, Physiology and Immunology, Faculty of Medicine and 3 Department of Biochemistry and Molecular Biology, Veterinary Faculty, University of Córdoba, 14071 Córdoba, Spain

Abstract

Glutaredoxin (Grx) is a small protein with oxidoreductase activity which is involved in the cellular defence against oxidative stress. Corpus luteum (CL) regression has been related to the generation of reactive oxygen species (ROS). We have studied the presence of glutaredoxin in the human ovary during the ovulatory cycle using polyclonal antibodies developed against recombinant human Grx. Immunostaining was only detected between days 15 and 23 of the cycle and was localized exclusively in the corpus luteum. Grx-positive cells corresponded to granulosa-derived luteal cells (GLC) whereas the remaining luteal cell types were not immunostained. In general, Grx immunoreactivity was parallel to the functional activity of the CL. Most GLC were immunostained on days 15–16 of the cycle, whereas on days 17–19 immunoreaction was found mainly at the inner and outer aspects of the granulosa lutein layer (GLL). After this stage only isolated GLC showed Grx immunoreactivity and no reaction was found from day 23 of the cycle onward. In two CL of pregnancy that were also studied, isolated GLC showed Grx immunoreactivity. Loss of Grx immunoreactivity was coincident with the appearance of morphological signs of structural luteolysis, such as shrinkage of the GLL and the presence of apoptotic cells. These data suggest that Grx, as a cellular antioxidant, plays an important role in the mechanisms of human CL development.

corpus luteum regression/glutaredoxin/luteinization/oxidative stress/redox regulation

Notes

4 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
R Gonzalez-Fernandez, F Gaytan, E Martinez-Galisteo, P Porras, C A Padilla, J E Sanchez Criado, and J A Barcena
Expression of glutaredoxin (thioltransferase) in the rat ovary during the oestrous cycle and postnatal development
J. Mol. Endocrinol., June 1, 2005; 34(3): 625 - 635.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Gaytan, C. Morales, M. L. Barreiro, P. Jeffery, L. K. Chopin, A. C. Herington, F. F. Casanueva, E. Aguilar, C. Dieguez, and M. Tena-Sempere
Expression of Growth Hormone Secretagogue Receptor Type 1a, the Functional Ghrelin Receptor, in Human Ovarian Surface Epithelium, Mullerian Duct Derivatives, and Ovarian Tumors
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1798 - 1804.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Gaytan, M. L. Barreiro, J. E. Caminos, L. K. Chopin, A. C. Herington, C. Morales, L. Pinilla, R. Paniagua, M. Nistal, F. F. Casanueva, et al.
Expression of Ghrelin and Its Functional Receptor, the Type 1a Growth Hormone Secretagogue Receptor, in Normal Human Testis and Testicular Tumors
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 400 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Gaytan, M. L. Barreiro, L. K. Chopin, A. C. Herington, C. Morales, L. Pinilla, F. F. Casanueva, E. Aguilar, C. Dieguez, and M. Tena-Sempere
Immunolocalization of Ghrelin and Its Functional Receptor, the Type 1a Growth Hormone Secretagogue Receptor, in the Cyclic Human Ovary
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 879 - 887.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Stavreus-Evers, B. Masironi, B.-M. Landgren, A. Holmgren, H. Eriksson, and L. Sahlin
Immunohistochemical localization of glutaredoxin and thioredoxin in human endometrium: a possible association with pinopodes
Mol. Hum. Reprod., June 1, 2002; 8(6): 546 - 551.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
L. Sahlin, H. Wang, Y. Stjernholm, M. Lundberg, G. Ekman, A. Holmgren, and H. Eriksson
The expression of glutaredoxin is increased in the human cervix in term pregnancy and immediately post-partum, particularly after prostaglandin-induced delivery
Mol. Hum. Reprod., December 1, 2000; 6(12): 1147 - 1153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Daily, A. Vlamis-Gardikas, D. Offen, L. Mittelman, E. Melamed, A. Holmgren, and A. Barzilai
Glutaredoxin Protects Cerebellar Granule Neurons from Dopamine-induced Apoptosis by Dual Activation of the Ras-Phosphoinositide 3-Kinase and Jun N-terminal Kinase Pathways
J. Biol. Chem., June 8, 2001; 276(24): 21618 - 21626.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.